FrancophonIA/ELRC3.0 huggingface dataset:
English: Docetaxel Accord 20 mg/1 ml is supplied in a 5 ml clear glass vial with fluorotec plus rubber stopper and aluminium seal and an orange flip-off cap.
Danish: Docetaxel Accord 20 mg/1 ml leveres i et 5 ml klart glashætteglas med fluorotec plus gummilukning og aluminiumforsegling og en orange afrivningshætte.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Docetaxel Accord 160 mg/8 ml sterile concentrate docetaxel
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Docetaxel Accord 160 mg/8 ml sterilt koncentrat docetaxel intravenøs anvendelse
English: Description of selected adverse reactions in breast cancer for docetaxel 100 mg/m2 single agent
Danish: Beskrivelse af udvalgte bivirkninger ved behandling af brystkræft for docetaxel 100 mg/m² enkeltstof
English: Docetaxel Accord 80 mg/4 ml concentrate for solution for infusion Clear glass (type I) vial with fluorotec plus (ethylene tetrafluoroethylene film) rubber stopper and aluminium seal and a red flip-off cap, containing 4 ml of concentrate.
Danish: Docetaxel Accord 80 mg/4 ml koncentrat til infusionsvæske, opløsning Klart glas (type I) hætteglas med fluorotec plus (ethylentetrafluoroethylenfilm) gummilukning og aluminiumforsegling og en rød afrivningshætte, indeholdende 4 ml koncentrat.
English: Pain in extremity (G3/4: < 1%); Back pain (G3/4: 1%)
Danish: Smerter i ekstremiteterne (G3/4: Rygsmerter (G3/4: 1 %);
English: After 10 years of follow-up in GEICAM 9805 study acute leukaemia occurred in 1 of 532 (0.2%) patients in TAC arm No cases were reported in patients in FAC arm No patient was diagnosed with myelodysplastic syndrome in either treatment groups.
Danish: Efter 10 års opfølgning i GEICAM9805-studiet forekom akut leukæmi hos 1 ud af 532 (0,2%) patienter i TAC-armen.
English: lymphoedema was observed to be ongoing in 4 patients (0.8%) in TAC arm, and in 1 patient (0.2%) in FAC arm.
Danish: I slutningen af opfølgningsperioden blev lymfødem observeret at være vedvarende hos 4 patienter (0,8 %) i TAC-armen og hos 1 patient (0,2 %) i FACarmen.
English: 50 vol % ethanol anhydrous (alcohol), i.e. up to 3.16 g ethanol anhydrous per vial, equivalent to 80 ml of beer or 33 ml wine.
Danish: Docetaxel Accord 160 mg/8 ml indeholder 50 % vol. vandfri ætanol (alkohol), dvs. op til 3,16 g vandfri ætanol pr. hætteglas, svarende til 80 ml øl eller 33 ml vin.
English: 50 vol % ethanol anhydrous (alcohol), i.e. up to 1.58 g ethanol anhydrous per vial, equivalent to 40 ml of beer or 17 ml wine.
Danish: Docetaxel Accord 80 mg/4 ml indeholder 50 % vol. vandfri ætanol (alkohol), dvs. op til 1,58 g vandfri ætanol pr. hætteglas, svarende til 40 ml øl eller 17 ml vin.
English: Tabulated list of adverse reactions in non-small cell lung cancer for docetaxel 75 mg/m2 single agent
Danish: Tabel over bivirkninger ved behandling af ikke-småcellet lungekræft med docetaxel 75 mg/m² enkeltstof:
English: NAME OF THE MEDICINAL PRODUCT Docetaxel Accord 20 mg/1 ml concentrate for solution for infusion docetaxel
Danish: Docetaxel Accord 20 mg/1 ml koncentrat til infusionsvæske, opløsning docetaxel
English: One vial of 1 ml of concentrate contains 20 mg of docetaxel.
Danish: Et hætteglas på 1 ml koncentrat indeholder 20 mg docetaxel.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Docetaxel Accord 80 mg/4 ml sterile concentrate docetaxel
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Docetaxel Accord 80 mg/4 ml sterilt koncentrat docetaxel intravenøs anvendelse
English: Tabulated list of adverse reactions in breast cancer for docetaxel 75 mg/m2 in combination with capecitabine
Danish: Tabel over bivirkninger ved behandling af brystkræft med docetaxel 75 mg/m² i kombination med capecitabin:
English: NAME OF THE MEDICINAL PRODUCT Docetaxel Accord 160 mg/8 ml concentrate for solution for infusion docetaxel
Danish: Docetaxel Accord 160 mg/8 ml koncentrat til infusionsvæske, opløsning docetaxel
English: Docetaxel Accord 20 mg/1 ml contains
Danish: Koncentrationen af docetaxel i Docetaxel Accord 20 mg/1 ml er 20 mg/ml
English: Epistaxis; Pharyngolaryngeal pain; Nasopharyngitis;
Danish: Luftveje, thorax og mediastinum Epistaxis; pharyngolaryngeal smerte; nasopharyngitis; dyspnø; hoste; næseflåd
English: The following information is intended for healthcare professionals only: PREPARATION GUIDE FOR USE WITH DOCETAXEL ACCORD CONCENTRATE FOR SOLUTION FOR INFUSION
Danish: FREMSTILLINGSVEJLEDNING TIL BRUG VED DOCETAXEL ACCORD KONCENTRAT TIL INFUSIONSVÆSKE, OPLØSNING
English: One vial of 4 ml of concentrate contains 80 mg of docetaxel.
Danish: Et hætteglas på 4 ml koncentrat indeholder 80 mg docetaxel.
English: Tabulated list of adverse reactions in breast cancer for docetaxel 100 mg/m2 in combination with trastuzumab
Danish: Tabel over bivirkninger ved behandling af brystkræft med docetaxel 100 mg/m² i kombination med trastuzumab:
English: Each box contains one vial of 8 ml concentrate.
Danish: Hver karton indeholder et hætteglas med 4 ml koncentrat Hver karton indeholder et hætteglas med 8 ml koncentrat
English: Docetaxel Accord 80 mg/4 ml is supplied in a 5 ml clear glass vial with fluorotec plus rubber stopper and aluminium seal and a red flip-off cap.
Danish: Docetaxel Accord 80 mg/4 ml leveres i et 5 ml klart glashætteglas med fluorotec plus gummilukning og aluminiumforsegling og en rød afrivningshætte.
English: Asthenia (severe: 12.4%); Fluid retention (severe: 0.8%); Pain
Danish: Asteni (alvorlig: 12,4 %); Væskeretention (alvorlig: Smerter
English: NAME OF THE MEDICINAL PRODUCT Docetaxel Accord 80 mg/4 ml concentrate for solution for infusion docetaxel
Danish: Docetaxel Accord 80 mg/4 ml koncentrat til infusionsvæske, opløsning docetaxel
English: Tabulated list of adverse reactions in breast cancer for docetaxel 75 mg/m2 in combination with doxorubicin
Danish: Tabel over bivirkninger ved behandling af brystkræft med docetaxel 75 mg/m² i kombination med doxorubicin:
English: For the induction treatment of patients with locally advanced (technically unresectable, low probability of surgical cure, and aiming at organ preservation) squamous cell carcinoma of the head and neck (SCCHN), the recommended dose of docetaxel is 75 mg/m2 as a 1 hour intravenous infusion on day 1, followed by cisplatin 100 mg/m2 administered as a 30-minute to 3-hour infusion, followed by 5-fluorouracil 1000 mg/m2/day as a continuous infusion from day 1 to day 4.
Danish: • Induktions kemoterapi efterfulgt af kemo-stråleterapi (TAX 324) Til den indledende behandling af patienter med lokalt fremskreden pladecellecarcinom i hoved og hals (SCCHN) (ikke muligt af resektere, lav sandsynlighed for kirurgisk helbredelse samt med bevarelse af organer som mål), er den anbefalede dosis docetaxel 75 mg/m2 som en 1-times intravenøs infusion på dag 1, efterfulgt af cisplatin 100 mg/m2 administreret som en 30 minutter til
English: Docetaxel Accord monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy.
Danish: Docetaxel Accord monoterapi er indiceret til behandling af patienter med lokalt fremskreden eller metastatisk brystkræft efter behandlingssvigt af kemoterapi.
English: Tabulated list of adverse reactions in head and neck cancer for docetaxel 75 mg/m2 in combination with cisplatin and 5-fluorouracil
Danish: Tabel over bivirkninger ved behandling af hoved- og halskræft med docetaxel 75 mg/m² i kombination med cisplatin og 5-fluoruracil:
English: Docetaxel in combination with trastuzumab
Danish: Docetaxel i kombination med trastuzumab
English: Stomatitis (G3/4: 1.7%); Vomiting (G3/4: 0.8%);
Danish: Stomatitis (G3/4: 1,7 %); Opkastning (G3/4: 0,8 %); Diarré (G3/4: 1,7 %)
English: Rash pruritus (G3/4: 0.7%); Nail disorders (G3/4: 0.7%); Skin exfoliation (G3/4: 0%)
Danish: Kløende udslæt (G3/4: 0,7 %); Neglesygdomme (G3/4: 0,7 %); Hudafskalning (G3/4: 0 %)
English: Docetaxel Accord 80 mg/4 ml concentrate for solution for infusion Each vial of concentrate contains 2 ml of ethanol anhydrous (1.58 g).
Danish: Docetaxel Accord 160 mg/8 ml koncentrat til infusionsvæske, opløsning Hvert hætteglas med koncentrat indeholder 2 ml vandfri ætanol (1,58 mg).
English: Stomatitis (G3/4: 2%)
Danish: Neglesygdomme (G3/4: 2 %)
English: patients were randomised to receive either docetaxel 75 mg/m2 administered 1-hour after doxorubicin 50 mg/m2 and cyclophosphamide 500 mg/m2 (TAC arm), or doxorubicin 50 mg/m2 followed by fluorouracil 500 mg/m2 and cyclosphosphamide 500 mg/m2 (FAC arm).
Danish: Efter stratificering i henhold til antallet af positive lymfeknuder (1-3, 4+), blev 1491 patienter randomiseret til enten at få enten docetaxel 75 mg/m2 administreret en time efter doxorubicin 50 mg/m2 og cyclophosphamid 500 mg/m2 (TAC-arm), eller doxorubicin 50 mg/m2, fulgt af fluoruracil 500 mg/ m2 og cyclophosphamid 500 mg/m2 (FAC-arm).
English: Tabulated list of adverse reactions in gastric adenocarcinoma cancer for docetaxel 75 mg/m2 in combination with cisplatin and 5-fluorouracil
Danish: Tabel over bivirkninger ved behandling af gastrisk adenokarcinom med docetaxel 75 mg/m² ikombination med cisplatin og 5-fluoruracil:
English: Stomatitis (G3/4: 5.3%); Diarrhoea (G3/4: 4%);
Danish: Mave-tarmkanalen Stomatitis (G3/4: Diarré (G3/4: 4 %);
English: Myalgia (G3/4: 0.7%); Arthralgia (G3/4:
Danish: Myalgi (G3/4: 0,7 %); Artralgi (G3/4: 0,2 %)
English: Docetaxel Accord 20 mg/1 ml concentrate for solution for infusion Each vial of concentrate contains 0.5 ml of ethanol anhydrous (395 mg).
Danish: Hjælpestof(fer), som behandleren skal være opmærksom på Docetaxel Accord 20 mg/1 ml koncentrat til infusionsvæske, opløsning Hvert hætteglas med koncentrat indeholder 0,5 ml vandfri ætanol (395 mg).
English: Alopecia ( persisting: Skin disorder (G3/4:
Danish: Hud og subkutane væv Alopeci; Hudlidelser (G3/4:
English: Diarrhoea grade 4 First episode: reduce docetaxel and 5-FU doses by 20%.
Danish: Første episode: Reducer docetaxel- og 5-FU-dosis med 20 % Anden episode: Afbryd behandlingen
English: Nausea (G3/4: 9.6%); Vomiting (G3/4:
Danish: Mave-tarmkanalen Kvalme (G3/4: 9,6 %); Opkastning (G3/4:
English: Arthralgia
Danish: Letargi
English: CAUTION: Ready to add to infusion solution
Danish: ANVENDELSESMÅDE OG ADMINISTRATIONSVEJ(E) BEMÆRK: Klar til tilsætning til infusionsvæske.
English: Fluid retention (severe: Fever (G3/4: 1.2%)
Danish: Væskeretention G3/4: Ødemer (G3/4: 1,2%)
English: Endpoint
Danish: ENDEPUNKT
English: Constipation (G3/4:
Danish: Konstipation (G3/4:
English: Patients on the docetaxel arm received docetaxel (T) 75 mg/m² by intravenous infusion on day 1 followed by cisplatin (P) 100 mg/m² administered as a 30-minute to three-hour intravenous infusion, followed by the continuous intravenous infusion of 5-fluorouracil (F) 1000 mg/m²/day from day 1 to day 4.
Danish: Patienter i docetaxel-armen fik docetaxel (T) 75 mg/m2 ved intravenøs infusion på dag 1, efterfulgt af cisplatin (P) 100 mg/m2 administreret som en 30 minutter til
English: 50 vol % ethanol anhydrous (alcohol), i.e. up to 395 mg ethanol anhydrous per vial, equivalent to 10 ml of beer or 4 ml wine.
Danish: Docetaxel Accord 20 mg/1 ml indeholder 50 % vol. vandfri ætanol (alkohol), dvs. op til 395 mg vandfri ætanol pr. hætteglas, svarende til 10 ml øl eller 4 ml vin.
English: Tabulated list of adverse reactions in breast cancer for docetaxel 100 mg/m2 single agent
Danish: Tabel over bivirkninger ved behandling af brystkræft med docetaxel 100 mg/m² enkeltstof:
English: Thrombocytopenia (G3/4: Febrile neutropenia
Danish: Trombocytopeni; (G3/4: 0,6 %); Febril neutropeni
English: In study GEICAM 9805 peripheral oedema that started during the treatment period persisted into the follow-up period in 4 patients (0.8%) in TAC arm and in 2 patients (0.4%) in FAC arm. At the end of the follow-up period (median follow-up time of 10 years and 5 months), no patients (0%) in TAC arm had peripheral oedema and it was observed to be ongoing in 1 patient (0.2%) in FAC arm.
Danish: I studiet GEICAM 9805 blev det observeret, at perifert ødem, som forekom i løbet af behandlingsperiden, fortsatte ind i opfølgningsperioden hos 4 patienter (0,8 %) i TAC-armen og hos 2 patienter (0,4 %) i FAC-armen.
English: Peripheral sensory neuropathy (G3/4: 0.6%)
Danish: Dysgeusi/parosmi Perifer sensorisk neuropati (G3/4: 0,6 %)
English: Weight increased (G3/4: 0%);
Danish: Forhøjet lakrimation (G3/4: 0 %)
English: This regimen is administered every
Danish: Dette regime blev administreret hver 3. uge i 4
English: (G3/4: 1.2%)
Danish: Feber (G3/4: 1,2 %)
English: Diarrhoea (G3/4: 1.7%)
Danish: Diarré (G3/4: 19,7 %);
English: 3 weeks for 4 cycles.
Danish: 4.4 og pkt.
English: 95% CI p-value*
Danish: 95 %CI P = Hazard ratio*
English: How to store Docetaxel Accord Keep this medicine out of the sight and reach of children.
Danish: Opbevar dette lægemiddel utilgængeligt for børn.
English: Vomiting (G3/4:
Danish: Svimmelhed (G3/4:
English: Arrhythmia (G3/4: 0.7%)
Danish: Arytmi (G3/4: 0,7 %) Hjertesvigt
English: In GEICAM 9805 study alopecia that started during the treatment period and persisted into the follow-up period was observed to be ongoing in 49 patients (9.2 %) in TAC arm and 35 patients (6.7 %) in FAC arm. Alopecia related to study drug started or worsened during the follow-up period in 42 patients (7.9 %) in TAC arm and 30 patients (5.8 %) in FAC arm. At the end of the follow-up period (median follow-up time of 10 years and 5 months), alopecia was observed to be ongoing in 3 patients (0.6%) in TAC arm, and in 1 patient (0.2%) in FAC arm.
Danish: I studiet GEICAM9805 fortsatte alopeci, som forekom i løbet af behandlingsperioden, og blev fortsat observeret hos 49 patienter (9,2%) i TAC-armen og hos 35 patienter (6,7%) i FAC-armen.
English: Date of first authorisation:12 June 2009
Danish: Dato for første markedsføringstilladelse: 12. juni 2009
English: The absolute bioavailability from the tablet was found to be about 77 %.
Danish: Den absolutte biotilgængelighed for en tablet er omkring 77%.
English: The most commonly reported adverse reactions are diarrhoea and headache, both occuring in approximately 1% of patients.
Danish: De hyppigst rapporterede bivirkninger er diaré og hovedpine, som begge forekommer hos ca. 1 % af patienterne.
English: The absorption of atazanavir is pH-dependent.
Danish: Absorptionen af atazanavir er pH-afhængig.
English: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).
Danish: Meget almindelig (≥1/10); almindelig (≥1/100 til <1/10); ikke almindelig (≥1/1.000 til < 1/100); sjælden (≥1/10.000 til <1/1.000); meget sjælden (<1/10.000), ikke kendt (kan ikke estimeres ud fra forhåndenværende data).
English: GORD diagnosis in these studies was based on endoscopic assessment, with the exception of one study in which the inclusion of the patients was based on symptomatology alone.
Danish: GORDdiagnosen i disse studier er baseret på endoskopisk vurdering, med undtagelse af et enkelt studie, hvor inkluderingen af patienter alene var baseret på symptomatologi.
English: The slight increase in AUC and Cmax in elderly volunteers compared with younger subjects was not clinically relevant.
Danish: Den lille stigning i AUC og Cmax hos ældre forsøgspersoner i forhold til yngre har ingen klinisk relevans.
English: Approximately 5% of patients can be expected to experience adverse reactions .
Danish: Det forventes, at der i gennemsnit er 5 % af patienterne, som oplever bivirkninger.
English: • They are on continuous symptomatic treatment of indigestion or heartburn for 4 or more weeks.
Danish: • de er under kontinuerlig symptomatisk behandling af fordøjelsesbesvær eller halsbrand i mere end 4 uger.
English: PANTECTA Control 20 mg gastro-resistant tablets should not be chewed or crushed, and should be swallowed whole with liquid before a meal.
Danish: PANTECTA Control 20 mg enterotabletter bør ikke tygges eller knuses, men skal sluges hele med væske før et måltid.
English: PANTECTA Control has no or negligible influence on the ability to drive and use machines.
Danish: PANTECTA Control påvirker ikke eller kun i ubetydelig grad evnen til at føre motorkøretøj og betjene maskiner.
English: Patients should not take another proton pump inhibitor or H2 antagonist concomitantly.
Danish: Patienter bør ikke tage andre protonpumpehæmmere eller H2-antagonister samtidigt .
English: It is unknown whether pantoprazole is excreted in human breast milk.
Danish: Det er ukendt, om pantoprazol udskilles i humanmælk .
English: Do not take PANTECTA Control: - if you are allergic to pantoprazole or to any of the other ingredients of this medicine (listed in section 6).
Danish: Tag ikke PANTECTA Control: - hvis du er allergisk over for pantoprazol eller et af de øvrige indholdsstoffer (angivet i afsnit 6
English: Especially, patients over 55 years taking any non-prescription indigestion or heartburn remedy on a daily basis should inform their pharmacist or doctor.
Danish: Specielt patienter over 55 år, som dagligt tager ikkereceptpligtige lægemidler mod fordøjelsesbesvær og halsbrand, bør informere deres apotek eller læge.
English: PANTECTA Control should not be used by children and adolescents under 18 years of age due to a lack of safety information in this younger age group..
Danish: PANTECTA Control må ikke bruges af børn og unge under 18 år pga. manglende dokumentation for sikkerhed i denne aldersgruppe.
English: PANTECTA Control is not recommended for use in children and adolescents below 18 years of age due to insufficient data on safety and efficacy.
Danish: PANTECTA Control bør ikke anvendes til børn og unge under 18 år på grund af utilstrækkelige data vedrørende sikkerhed og virkning.
English: In animal studies (rats) 5 mg/kg was the observed NOAEL (No Observed Adverse Effect Level) for embryotoxicity.
Danish: I dyrestudier (rotter) var den observerede NOAEL (intet bivirkningsniveau observeret) 5 mg/kg for embryotoksicitet.
English: Stop taking PANTECTA Control when you are completely symptom-free.
Danish: Stop med at tage PANTECTA Control, når du er symptomfri.
English: - The other ingredients are:
Danish: - Øvrige indholdsstoffer :
English: Liver enzymes increased (transaminases, γ-GT)
Danish: Forhøjede leverenzymer (transaminaser, γ-GT)
English: If you take more PANTECTA Control than you should Tell your doctor or pharmacist if you have taken more than the recommended dose.
Danish: Hvis du har taget for meget PANTECTA Control Fortæl det til lægen eller apoteket hvis du har taget mere end den anbefalede dosis.
English: PANTECTA Control is available in Alu/Alu blisters with or without cardboard reinforcement.
Danish: PANTECTA Control findes i aluminim/aluminium-blister med eller uden kartonforstærkning.
English: Do not take PANTECTA Control with other medicines which limit the amount of acid produced in your stomach, such as another proton pump inhibitor (omeprazole, lansoprazole or rabeprazole) or an H2 antagonist (e.g. ranitidine, famotidine).
Danish: Tag ikke PANTECTA Control samtidigt med anden medicin, som begrænser mængden af syre i din mave, så som andre syrepumpehæmmere (omeprazol, lansoprazol eller rabeprazol) eller en H2antagonist (f.eks. ranitidin, famotidin).
English: After 14 and 28 days, complete heartburn relief was experienced in 62.9% to 88.6% and 68.1% to 92.3% of the patients, respectively.
Danish: Efter 14 og 28 dage oplevede henholdsvis 62,9 % til 88,6 % og 68,1 % til 92,3 % af patienterne fuldstændig lindring af halsbranden.
English: It has been shown that co-administration of atazanavir 300 mg/ritonavir 100 mg with omeprazole (40 mg once daily) or atazanavir 400 mg with lansoprazole (60 mg single dose) to healthy volunteers resulted in a substantial reduction in the bioavailability of atazanavir.
Danish: Det er vist, at samtidig anvendelse af atazanavir 300 mg/ ritonavir 100 mg og omeprazol (40 mg én gang daglig) eller atazanavir 400 mg og lanzoprazol (60 mg givet som enkeltdosis) hos raske forsøgspersoner har medført en betydelig reduktion i atazanavirs biotilgængelighed.
English: PANTECTA Control contains the active substance pantoprazole, which blocks the ‘pump' that produces stomach acid.
Danish: PANTECTA Control indeholder det aktive stof pantoprazol, som blokerer den ”pumpe”, der producerer mavesyre.
English: You must not use PANTECTA Control if you are taking atazanavir.
Danish: Du må ikke tage PANTECTA Control, hvis du tager atazanavir.
English: In these studies, the percentage of patients experiencing complete relief from heartburn after 7 days was between 54.0% and 80.6% in the pantoprazole group.
Danish: I disse studier var procentdelen af de patienter, som opnåede fuldstændig lindring af halsbranden efter 7 dage, mellem 54,0% og 80,6 % i gruppen som blev behandlet med pantoprazol.
English: See ‘Do not take PANTECTA Control'.
Danish: Se 'tag ikke PANTECTA Control'.
English: You may need further blood tests - methotrexate (used to treat rheumatoid arthritis, psoriasis, and cancer) - if you are taking methotrexate your doctor may temporarily stop your PANTECTA Control treatment because pantoprazole can increase levels of methotrexate in the blood.
Danish: - Methotrexat (bruges til behandling af reumatoid artrit, psoriasis og cancer) - hvis du tager methotrexat, kan din læge midlertidigt stoppe din behandling med PANTECTA Control, da PANTECTA Control kan forøge niveauet af methotrexat i blodet.
English: Therefore, pantoprazole must not be co-administered with atazanavir (see section 4.3).
Danish: Derfor bør pantoprazol ikke gives sammen med atazanavir (se pkt.
English: PANTECTA Control may reduce the absorption of active substances whose bioavailability is dependent on the gastric pH (e.g. ketoconazole).
Danish: PANTECTA Control kan reducere absorptionen af aktive stoffer, hvis biotilgængelighed er pHafhængig (fx. ketoconazol).
English: Animal studies have shown excretion of pantoprazole in breast milk.
Danish: Dyrestudier har vist, at pantoprazol udskilles i brystmælk.
English: Pharmacotherapeutic group: : Drugs for acid related disorders,Proton pump inhibitors, ATC code: A02BC02
Danish: Farmakoterapeutisk klassifikation: Protonpumpehæmmere, ATC-kode: A02BC02
English: Hyponatraemia, Hypomagnesaemia
Danish: Hyponatræmi, hypomagnesæmi
English: Therefore, in patients treated with coumarin anticoagulants (e.g. phenprocoumon or warfarin), monitoring of prothrombin time/INR is recommended after initiation, termination or during irregular use of pantoprazole.
Danish: Derfor bør patienter, der er i behandling med kumarinantikoagulantia (f.eks. phenprocoumon eller warfarin), have foretaget ekstra analyser af prothrombintid/INR ved behandlingsstart og -ophør samt ved uregelmæssig brug af pantoprazol.
English: You may experience relief from your acid reflux and heartburn symptoms after just one day of treatment with PANTECTA Control, but this medicine is not meant to bring immediate relief.
Danish: Du kan opleve lindring af dine symptomer på sure opstød og halsbrand efter kun en dags behandling med PANTECTA Control, men denne medicin har ikke til hensigt at give øjeblikkelig lindring.
English: However, you may take PANTECTA Control with antacids (e.g. magaldrate, alginic acid, sodium bicarbonate, aluminium hydroxide, magnesium carbonate, or combinations thereof), if needed.
Danish: Du må gerne tage PANTECTA Control samtidig med syreneutraliserende medicin (f.eks. magaldrat, alginsyre, natriumbicarbonat, aluminiumhydroxid, magnesiumcarbonat eller kombinationer heraf), hvis det er nødvendigt.
English: Pantoprazole should not be used during pregnancy.
Danish: PANTECTA Control bør ikke anvendes under graviditet.
English: - if you are taking a medicine containing atazanavir (for the treatment of HIV-infection) See
Danish: - hvis du tager medicin, som indeholder atazanavir (til behandling af HIV-infektion).
English: Do not take PANTECTA Control tablets for more than 4 weeks without consulting your doctor.
Danish: Tag ikke PANTECTA Control-tabletter i mere end 4 uger uden at kontakte lægen.